Literature DB >> 22506850

Chromosomal bacterial type II toxin-antitoxin systems.

Mohammad Adnan Syed1, Céline M Lévesque.   

Abstract

Most prokaryotic chromosomes contain a number of toxin-antitoxin (TA) modules consisting of a pair of genes that encode 2 components, a stable toxin and its cognate labile antitoxin. TA systems are also known as addiction modules, since the cells become "addicted" to the short-lived antitoxin product (the unstable antitoxin is degraded faster than the more stable toxin) because its de novo synthesis is essential for their survival. While toxins are always proteins, antitoxins are either RNAs (type I, type III) or proteins (type II). Type II TA systems are widely distributed throughout the chromosomes of almost all free-living bacteria and archaea. The vast majority of type II toxins are mRNA-specific endonucleases arresting cell growth through the mechanism of RNA cleavage, thus preventing the translation process. The physiological role of chromosomal type II TA systems still remains the subject of debate. This review describes the currently known type II toxins and their characteristics. The different hypotheses that have been proposed to explain their role in bacterial physiology are also discussed.

Mesh:

Substances:

Year:  2012        PMID: 22506850     DOI: 10.1139/w2012-025

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  10 in total

1.  Crystal structure of the toxin Msmeg_6760, the structural homolog of Mycobacterium tuberculosis Rv2035, a novel type II toxin involved in the hypoxic response.

Authors:  R Alexandra Bajaj; Mark A Arbing; Annie Shin; Duilio Cascio; Linda Miallau
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-11-19       Impact factor: 1.056

2.  Cell growth inhibition upon deletion of four toxin-antitoxin loci from the megaplasmids of Sinorhizobium meliloti.

Authors:  Branislava Milunovic; George C diCenzo; Richard A Morton; Turlough M Finan
Journal:  J Bacteriol       Date:  2013-12-06       Impact factor: 3.490

Review 3.  Evolutionary Genomics of Defense Systems in Archaea and Bacteria.

Authors:  Eugene V Koonin; Kira S Makarova; Yuri I Wolf
Journal:  Annu Rev Microbiol       Date:  2017-06-28       Impact factor: 15.500

4.  Posttranscriptional regulation of oral bacterial adaptive responses.

Authors:  Justin Merritt; Zhiyun Chen; Nan Liu; Jens Kreth
Journal:  Curr Oral Health Rep       Date:  2014-03-01

5.  Identification of Three Type II Toxin-Antitoxin Systems in Streptococcus suis Serotype 2.

Authors:  Jiali Xu; Nian Zhang; Manman Cao; Sujing Ren; Ting Zeng; Minglu Qin; Xigong Zhao; Fangyan Yuan; Huanchun Chen; Weicheng Bei
Journal:  Toxins (Basel)       Date:  2018-11-13       Impact factor: 4.546

6.  Structural and functional analysis of the Klebsiella pneumoniae MazEF toxin-antitoxin system.

Authors:  Chenglong Jin; Sung-Min Kang; Do-Hee Kim; Bong-Jin Lee
Journal:  IUCrJ       Date:  2021-03-05       Impact factor: 4.769

7.  Characterization of a Streptococcus mutans intergenic region containing a small toxic peptide and its cis-encoded antisense small RNA antitoxin.

Authors:  Stephanie Koyanagi; Céline M Lévesque
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

Review 8.  Comparative genomics of defense systems in archaea and bacteria.

Authors:  Kira S Makarova; Yuri I Wolf; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2013-03-06       Impact factor: 16.971

9.  Comprehensive analysis of the HEPN superfamily: identification of novel roles in intra-genomic conflicts, defense, pathogenesis and RNA processing.

Authors:  Vivek Anantharaman; Kira S Makarova; A Maxwell Burroughs; Eugene V Koonin; L Aravind
Journal:  Biol Direct       Date:  2013-06-15       Impact factor: 4.540

10.  Functional Genomics of a Symbiotic Community: Shared Traits in the Olive Fruit Fly Gut Microbiota.

Authors:  Frances Blow; Anastasia Gioti; Ian B Goodhead; Maria Kalyva; Anastasia Kampouraki; John Vontas; Alistair C Darby
Journal:  Genome Biol Evol       Date:  2020-02-01       Impact factor: 3.416

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.